Disclosure: The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.
Main Article
Reliability of the modified hammersmith functional motor scale in young children with spinal muscular atrophy†
Article first published online: 22 JUN 2011
DOI: 10.1002/mus.22040
Copyright © 2011 Wiley Periodicals, Inc.
Additional Information
How to Cite
Krosschell, K. J., Scott, C. B., Maczulski, J. A., Lewelt, A. J., Reyna, S. P., Swoboda, K. J. and for Project Cure SMA (2011), Reliability of the modified hammersmith functional motor scale in young children with spinal muscular atrophy. Muscle Nerve, 44: 246–251. doi: 10.1002/mus.22040
- †
Publication History
- Issue published online: 13 JUL 2011
- Article first published online: 22 JUN 2011
- Accepted manuscript online: 1 FEB 2011 10:06AM EST
- Manuscript Accepted: 11 JAN 2011
Funded by
- Public Health Services. Grant Number: UL1-RR025764
- National Center for Research Resources. Grant Number: C06-RR11234
- Abstract
- Article
- References
- Cited By
Keywords:
- MHFMS;
- Modified Hammersmith Functional Motor Scale, outcome, spinal muscular atrophy, test–retest reliability
Abstract
Introduction: The test–retest reliability of the Modified Hammersmith Functional Motor Scale (MHFMS) in children with spinal muscular atrophy (SMA) ≤30 months of age was assessed. The age at which typically developing children (TD) achieve maximum MHFMS scores was also studied. Methods: Twenty-two children with SMA type II [mean age (SD) = 20 (5) months, range 9–30 months) were tested twice using the MHFMS. Twenty-five TD children [mean age (SD) = 18 (7) months, range 9–30 months) were tested once. Results: The average difference between MHFMS scores for SMA children was 0.18 [first assessment: mean (SD) = 12.8 (9.8); second assessment: mean (SD) = 13.0 (8.8)]. Reliability was excellent (ICC1,3 = 0.96, SEM 1.86). TD participants had MHFMS scores ranging from 36 to 40 [mean (SD) = 39.2 (1.2)] and achieved maximum test scores at 12 months of age. Discussion: MHFMS scores in young children with SMA type II showed excellent test–retest stability. This suggests that the MHFMS can be used reliably in this younger population for clinical trials and follow-up. Muscle Nerve, 2011

1097-4598/asset/MUS_centre.gif?v=1&s=dd26a8ef41e725ebc09f227054c39323dd54b146)
